packageDarolutamide

darolutamide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Darolutamide is an anti-androgen cancer medicine used to treat prostate cancer that no longer responds to hormone therapy. It is approved and authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q25091391 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:darolutamide
ATC codes:L02BB06
DrugBank:DB12941
PubChem CID:67171867
Wikidata:Q25091391
formula:C19H19ClN6O2
molar mass:398.851 g/mol (PubChem CID 67171867)
logP:1.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown